Form 4: Twist Bioscience COO Sells Shares to Cover Tax Obligations

Patrick John Finn, President and COO of Twist Bioscience, sold 2,800 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On May 5, 2025, Patrick John Finn, the President and COO of Twist Bioscience, sold 2,800 shares of common stock.
• The sale was executed at a price of $37.651 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Finn directly owns 262,660 shares of Twist Bioscience.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transaction is a routine sale to cover tax obligations, which is a common practice and doesn't necessarily reflect a positive or negative outlook on the company.

Management Comments

• The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

Executive stock sales are a common occurrence, especially to cover tax obligations related to equity compensation. The market typically views these sales differently than discretionary sales, as they are often pre-planned and less indicative of the executive's sentiment about the company's future performance.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

Keywords

Twist Bioscience, TWST, Patrick John Finn, Stock Sale, Form 4, Insider Trading, Restricted Stock Units, Tax Withholding